Flavonoids Against Cancer Hallmarks

Dr. Kashyap is currently at the Brown Center for Immunotherapy, Indiana University, working on identifying novel biomarkers for designing and modifying immunotherapy approaches for breast cancer targeting TME components. He received his PhD in molecular biology on the main subject of tumor microenvironment in breast cancer from PGIMER, Chandigarh, India, and holds an MSc in Human Genomics. He published 70 articles and five book chapters. He is also a reviewer and editorial board member of many PubMed/Scopus-indexed journals. His h-index is 26, and FWCI is 2.91Dr. Sharma is an early career scientist in biological science at the School of Medicine, Indiana University Indianapolis, USA, working on Multiple Myeloma genomics characterizations. She holds an MSc in Microbial Biotechnology and has good publications in peer-reviewed international journals.

• 1. Recent Update on Cancer Epidemiology2. Pros and Cons of Currently Available Chemotherapy3. Flavonoids, Their Classification, Chemistry, and Therapeutic Potential Against Different Types of Cancer4. Source of Flavonoid, Mode of Intake, Bioavailability and Possible Toxicity5. Flavonoids Against Immune Evasion During Carcinogenesis6. Apoptosis Inducing Potential of Flavonoids in Cancer7. Flavonoids As Cell Cycle Inhibitors in Cancer8. Flavonoids with Anti-angiogenetic Potential in Cancer9. Flavonoids As Promising Plant Derived Agents Against Cancer Invasion and Metastasis10. Promising Function of Flavonoid in the Inhibit of Epithelial to Mesenchymal Transition11. Flavonoids Mediated Regulation of Cancer Stemness Phenotype12. Role of Flavonoids in Epigenetic Regulation: A Mechanism for Their Anti-cancer Potential13. Synergistic Effects of Flavonoids with Other Anti-cancer Drugs: With Special References to Targeted and Immunotherapy14. Clinical Implication of Flavonoid: Integration with Clinical Trials and Future Directions

Select Guide Rating